Principal Financial Group’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-174,802
Closed -$30.1M 2706
2021
Q3
$30.1M Sell
174,802
-41,687
-19% -$7.17M 0.02% 652
2021
Q2
$27.2M Buy
216,489
+51,593
+31% +$6.47M 0.02% 735
2021
Q1
$22.4M Buy
164,896
+13,190
+9% +$1.79M 0.02% 825
2020
Q4
$19.4M Sell
151,706
-9,772
-6% -$1.25M 0.01% 792
2020
Q3
$18.2M Sell
161,478
-733
-0.5% -$82.5K 0.02% 715
2020
Q2
$15.5M Buy
162,211
+50,320
+45% +$4.79M 0.01% 786
2020
Q1
$10.1M Sell
111,891
-20,656
-16% -$1.86M 0.01% 899
2019
Q4
$7.03M Sell
132,547
-8,543
-6% -$453K 0.01% 1414
2019
Q3
$5.58M Sell
141,090
-5,146
-4% -$203K ﹤0.01% 1477
2019
Q2
$6.01M Buy
146,236
+781
+0.5% +$32.1K 0.01% 1469
2019
Q1
$6.77M Buy
145,455
+4,256
+3% +$198K 0.01% 1435
2018
Q4
$6.15M Sell
141,199
-9,945
-7% -$433K 0.01% 1426
2018
Q3
$8.65M Sell
151,144
-12,922
-8% -$739K 0.01% 1394
2018
Q2
$7.96M Buy
164,066
+28,575
+21% +$1.39M 0.01% 1415
2018
Q1
$5.3M Sell
135,491
-2,038
-1% -$79.7K 0.01% 1536
2017
Q4
$5.84M Buy
137,529
+32,507
+31% +$1.38M 0.01% 1516
2017
Q3
$3.92M Buy
105,022
+788
+0.8% +$29.4K ﹤0.01% 1621
2017
Q2
$3.17M Buy
104,234
+1,039
+1% +$31.6K ﹤0.01% 1675
2017
Q1
$2.73M Sell
103,195
-2,547
-2% -$67.4K ﹤0.01% 1685
2016
Q4
$2.7M Buy
105,742
+2,652
+3% +$67.7K ﹤0.01% 1672
2016
Q3
$3.73M Buy
103,090
+5,990
+6% +$217K ﹤0.01% 1558
2016
Q2
$3.3M Sell
97,100
-2,500
-3% -$84.9K ﹤0.01% 1545
2016
Q1
$2.63M Hold
99,600
﹤0.01% 1566
2015
Q4
$4.86M Buy
99,600
+4,800
+5% +$234K 0.01% 1380
2015
Q3
$2.36M Buy
94,800
+400
+0.4% +$9.96K ﹤0.01% 1601
2015
Q2
$2.99M Buy
94,400
+31,400
+50% +$994K ﹤0.01% 1587
2015
Q1
$2.4M Buy
63,000
+22,200
+54% +$845K ﹤0.01% 1618
2014
Q4
$1.59M Buy
40,800
+1,000
+3% +$39K ﹤0.01% 1724
2014
Q3
$1.2M Hold
39,800
﹤0.01% 1741
2014
Q2
$1.35M Hold
39,800
﹤0.01% 1748
2014
Q1
$1.37M Sell
39,800
-600
-1% -$20.7K ﹤0.01% 1727
2013
Q4
$1.6M Buy
+40,400
New +$1.6M ﹤0.01% 1708